CompletedNot Applicable

Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®

Belgium25 participantsStarted 2022-01-01

Plain-language summary

This clinical study aims aims to evaluate the clinical outcomes of SDL-PDT (simulated daylight Photodynamic Therapy) using the Dermaris in patients treated for AK lesions of the scalp at our medical dermatology center using only 35 minutes low-intensity light exposure.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * phototype 1 to 3, * grade I-II AK of the scalp * minimum of 9 clinically diagnosed grade I and II AK lesions of the scalp (according to the classification of Olsen) suggesting the existence of field cancerization Exclusion Criteria: * serious organic disorder, * incipient or established cognitive impairment * pregnancy * lactation, * to be receiving oral or parenteral pharmacological therapy which might interfere with the results.

What they're measuring

Lesion clearance rate

Timeframe: 1 year

Trial details

NCT IDNCT05522036

SponsorCentre Dermatologique du Roy

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Actinic Keratoses trials